A BILL 
To require the Director of the National Institutes of Health 
to conduct an evaluation of menopause-related research 
(including gaps in research and knowledge regarding the 
causes, symptoms, and treatments for menopause), to 
develop a strategic plan to resolve gaps in knowledge 
and research, and identify topics in need of further re-
search relating to potential treatments for menopause- 
related symptoms, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
21:42 Sep 06, 2022
H8774
2 
•HR 8774 IH
SECTION 1. SHORT TITLE. 
1
This Act may be cited as the ‘‘Menopause Research 
2
Act of 2022’’. 
3
SEC. 2. EVALUATION OF MENOPAUSE-RELATED RESEARCH. 
4
(a) IN GENERAL.—The Director of the National In-
5
stitutes of Health shall— 
6
(1) conduct an evaluation of— 
7
(A) the results of completed menopause-re-
8
lated research, and research on mid-life wom-
9
en’s health; 
10
(B) the status of ongoing menopause-re-
11
lated research, and research on mid-life wom-
12
en’s health; and 
13
(C) any gaps in knowledge and research 
14
on— 
15
(i) treatments for menopause-related 
16
symptoms; and 
17
(ii) the safety and effectiveness of 
18
treatments for menopause-related symp-
19
toms; and 
20
(2) as part of such evaluation, identify the total 
21
amount of funding allocated by the National Insti-
22
tutes of Health for the conduct or support of meno-
23
pause-related research, and research on mid-life 
24
women’s health over the preceding 5 fiscal years. 
25
21:42 Sep 06, 2022
H8774
3 
•HR 8774 IH
(b) REPORT; STRATEGIC PLAN.—Not later than 180 
1
days after the date of enactment of this Act, the Director 
2
of the National Institutes of Health shall submit to the 
3
Congress— 
4
(1) a report on the findings of such evaluation; 
5
and 
6
(2) a strategic plan— 
7
(A) to resolve the gaps in knowledge and 
8
research identified in the report; and 
9
(B) to identify topics in need of further re-
10
search relating to potential treatments for 
11
menopause-related symptoms. 
12
SEC. 3. MENOPAUSE-RELATED RESEARCH, AND RESEARCH 
13
ON MID-LIFE WOMEN’S HEALTH. 
14
(a) IN GENERAL.—The Secretary of Health and 
15
Human Services, acting through the Director of the Na-
16
tional Institutes of Health, shall conduct or support meno-
17
pause-related research, and research on mid-life women’s 
18
health. 
19
(b) AUTHORIZATION OF APPROPRIATIONS.—There is 
20
authorized to be appropriated to carry out this section 
21
$100,000,000 for each of fiscal years 2023 and 2024. 
22
Æ 
21:42 Sep 06, 2022
H8774
